Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors

INTRODUCTION: The failure of immune checkpoint inhibitor (ICPi) on glioblastoma (GBM) treatment underscores the need for improving therapeutic strategy. We aimed to change tumor associated macrophage (TAM) from M2 type (anti-inflammatory) to M1 (pro-inflammatory) type to increase the therapeutic res...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Sanford P. C., Chen, Yi-Ching, Chiang, Hsin-Chien, Huang, Yi-Chun, Huang, Cheng-Chung, Wang, Hsin-Ell, Wang, Yu-Shang, Chi, Kwan-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Laboratory Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000510/
https://www.ncbi.nlm.nih.gov/pubmed/32020472
http://dx.doi.org/10.1007/s11060-019-03360-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000510/
https://www.ncbi.nlm.nih.gov/pubmed/32020472
http://dx.doi.org/10.1007/s11060-019-03360-3

Ejemplares similares